ATRA logo

Atara Biotherapeutics (ATRA) Cash From Investing

Annual CFI

$123.87 M
-$79.09 M-38.97%

31 December 2023

ATRA Cash From Investing Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly CFI

-$16.66 M
-$23.86 M-331.59%

30 September 2024

ATRA Quarterly CFI Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

TTM CFI

$15.19 M
-$87.11 M-85.15%

30 September 2024

ATRA TTM CFI Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

ATRA Cash From Investing Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-39.0%-123.7%-90.8%
3 y3 years+202.6%-1495.7%+56.8%
5 y5 years+163.1%+71.5%-85.6%

ATRA Cash From Investing High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3 years-39.0%+202.6%-123.7%+31.5%-92.5%+56.8%
5 y5 years-39.0%+163.1%-123.7%+87.2%-92.5%+110.2%
alltimeall time-39.0%+156.3%-123.7%+93.3%-92.5%+105.9%

Atara Biotherapeutics Cash From Investing History

DateAnnualQuarterlyTTM
Sept 2024
-
-$16.66 M(-331.6%)
$15.19 M(-85.2%)
June 2024
-
$7.20 M(-51.1%)
$102.30 M(-29.2%)
Mar 2024
-
$14.72 M(+48.0%)
$144.59 M(+16.7%)
Dec 2023
$123.87 M(-39.0%)
$9.94 M(-85.9%)
$123.87 M(-25.0%)
Sept 2023
-
$70.45 M(+42.4%)
$165.14 M(+7.0%)
June 2023
-
$49.48 M(-923.7%)
$154.39 M(+12.9%)
Mar 2023
-
-$6.01 M(-111.7%)
$136.73 M(-32.6%)
Dec 2022
$202.96 M(+811.8%)
$51.22 M(-14.2%)
$202.96 M(+59.3%)
Sept 2022
-
$59.70 M(+87.6%)
$127.41 M(+84.9%)
June 2022
-
$31.83 M(-47.1%)
$68.91 M(-0.1%)
Mar 2022
-
$60.22 M(-347.6%)
$68.97 M(+209.9%)
Dec 2021
$22.26 M(-118.4%)
-$24.32 M(-2137.2%)
$22.26 M(+129.7%)
Sept 2021
-
$1.19 M(-96.3%)
$9.69 M(-39.7%)
June 2021
-
$31.89 M(+136.2%)
$16.06 M(-111.0%)
Mar 2021
-
$13.50 M(-136.6%)
-$146.20 M(+21.1%)
Dec 2020
-$120.73 M(-299.7%)
-$36.89 M(-587.9%)
-$120.73 M(+46.0%)
Sept 2020
-
$7.56 M(-105.8%)
-$82.71 M(-44.4%)
June 2020
-
-$130.37 M(-434.5%)
-$148.79 M(-567.4%)
Mar 2020
-
$38.97 M(+3358.1%)
$31.84 M(-47.3%)
Dec 2019
$60.46 M(-130.8%)
$1.13 M(-101.9%)
$60.46 M(-42.6%)
Sept 2019
-
-$58.52 M(-216.4%)
$105.40 M(-39.9%)
June 2019
-
$50.25 M(-25.7%)
$175.35 M(+44.7%)
Mar 2019
-
$67.60 M(+46.7%)
$121.22 M(-161.8%)
DateAnnualQuarterlyTTM
Dec 2018
-$196.29 M(-296.5%)
$46.07 M(+302.8%)
-$196.29 M(-1.6%)
Sept 2018
-
$11.44 M(-395.0%)
-$199.39 M(-2.4%)
June 2018
-
-$3.88 M(-98.4%)
-$204.21 M(+8.6%)
Mar 2018
-
-$249.92 M(-681.6%)
-$188.03 M(-288.2%)
Dec 2017
$99.91 M(+19.3%)
$42.97 M(+549.6%)
$99.91 M(+25.3%)
Sept 2017
-
$6.62 M(-46.2%)
$79.73 M(-26.3%)
June 2017
-
$12.30 M(-67.6%)
$108.15 M(-2.5%)
Mar 2017
-
$38.02 M(+66.9%)
$110.90 M(+32.4%)
Dec 2016
$83.74 M(-138.0%)
$22.79 M(-35.0%)
$83.74 M(+101.6%)
Sept 2016
-
$35.04 M(+132.7%)
$41.53 M(-128.4%)
June 2016
-
$15.06 M(+38.6%)
-$146.39 M(-25.2%)
Mar 2016
-
$10.86 M(-155.9%)
-$195.83 M(-11.0%)
Dec 2015
-$220.13 M(+164.1%)
-$19.42 M(-87.3%)
-$220.13 M(-14.6%)
Sept 2015
-
-$152.89 M(+344.6%)
-$257.64 M(+142.6%)
June 2015
-
-$34.39 M(+156.0%)
-$106.19 M(+42.8%)
Mar 2015
-
-$13.43 M(-76.4%)
-$74.38 M(-10.8%)
Dec 2014
-$83.36 M(>+9900.0%)
-$56.94 M(+3864.8%)
-$83.36 M(+215.4%)
Sept 2014
-
-$1.44 M(-44.3%)
-$26.43 M(+5.7%)
June 2014
-
-$2.58 M(-88.5%)
-$24.99 M(>+9900.0%)
Mar 2014
-
-$22.41 M(<-9900.0%)
-$3000.00(0.0%)
Dec 2013
-$3000.00
$0.00(0.0%)
-$3000.00(0.0%)
Sept 2013
-
$0.00(-100.0%)
-$3000.00(0.0%)
June 2013
-
$22.41 M(-200.0%)
-$3000.00(-100.0%)
Mar 2013
-
-$22.41 M
-$22.41 M

FAQ

  • What is Atara Biotherapeutics annual cash flow from investing activities?
  • What is the all time high annual CFI for Atara Biotherapeutics?
  • What is Atara Biotherapeutics annual CFI year-on-year change?
  • What is Atara Biotherapeutics quarterly cash flow from investing activities?
  • What is the all time high quarterly CFI for Atara Biotherapeutics?
  • What is Atara Biotherapeutics quarterly CFI year-on-year change?
  • What is Atara Biotherapeutics TTM cash flow from investing activities?
  • What is the all time high TTM CFI for Atara Biotherapeutics?
  • What is Atara Biotherapeutics TTM CFI year-on-year change?

What is Atara Biotherapeutics annual cash flow from investing activities?

The current annual CFI of ATRA is $123.87 M

What is the all time high annual CFI for Atara Biotherapeutics?

Atara Biotherapeutics all-time high annual cash flow from investing activities is $202.96 M

What is Atara Biotherapeutics annual CFI year-on-year change?

Over the past year, ATRA annual cash flow from investing activities has changed by -$79.09 M (-38.97%)

What is Atara Biotherapeutics quarterly cash flow from investing activities?

The current quarterly CFI of ATRA is -$16.66 M

What is the all time high quarterly CFI for Atara Biotherapeutics?

Atara Biotherapeutics all-time high quarterly cash flow from investing activities is $70.45 M

What is Atara Biotherapeutics quarterly CFI year-on-year change?

Over the past year, ATRA quarterly cash flow from investing activities has changed by -$87.11 M (-123.66%)

What is Atara Biotherapeutics TTM cash flow from investing activities?

The current TTM CFI of ATRA is $15.19 M

What is the all time high TTM CFI for Atara Biotherapeutics?

Atara Biotherapeutics all-time high TTM cash flow from investing activities is $202.96 M

What is Atara Biotherapeutics TTM CFI year-on-year change?

Over the past year, ATRA TTM cash flow from investing activities has changed by -$149.95 M (-90.80%)